Calcipotriol ointment vs. betamethasone 17-valerate ointment in the treatment of lichen amyloidosis.
Khoo
B P
BP
National Skin Centre, Singapore, Singapore.
Tay
Y K
YK
Goh
C L
CL
D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000188:drug therapy* / Q000473:pathology; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001624:Betamethasone Valerate / Q000627:therapeutic use*; D002117:Calcitriol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007868:Leg Dermatoses / Q000188:drug therapy / Q000473:pathology; D017512:Lichenoid Eruptions / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010865:Pilot Projects; D011537:Pruritus / Q000139:chemically induced; D012867:Skin / Q000187:drug effects / Q000473:pathology; D013997:Time Factors; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D009824:Ointments; C055085:calcipotriene; D001624:Betamethasone Valerate; D002117:Calcitriol